Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.59 |
| ▸ | NPC1 | O15118 | 4/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.56 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.51 |
| ▸ | PKM | P14618 | 2/20 | 0.48 |
| ▸ | CRHBP | P24387 | 1/20 | 0.48 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6169173 | 0.93 | MAPT (0.65) | RAB9ANPC1MAPTGAAKMT2A | |
| SCHEMBL6172642 | 0.91 | RAB9A (0.56) | RAB9ANPC1MAPTGAAKMT2A | |
| SCHEMBL6169823 | 0.90 | KMT2A (0.50) | RAB9ANPC1MAPTKMT2AALDH1A1 | |
| SCHEMBL6172673 | 0.90 | KMT2A (0.52) | RAB9ANPC1MAPTKMT2AALDH1A1 | |
| SCHEMBL6169121 | 0.90 | L3MBTL1 (0.48) | RAB9ANPC1MAPTKMT2AALDH1A1 | |
| SCHEMBL6169822 | 0.90 | KMT2A (0.48) | RAB9ANPC1MAPTGAAKMT2A | |
| SCHEMBL6172439 | 0.88 | RAB9A (0.57) | RAB9ANPC1MAPTGAAKMT2A | |
| SCHEMBL6170284 | 0.87 | KMT2A (0.48) | RAB9ANPC1MAPTGAAKMT2A | |
| SCHEMBL6172423 | 0.87 | KMT2A (0.48) | RAB9ANPC1MAPTGAAKMT2A | |
| SCHEMBL6168620 | 0.86 | KMT2A (0.57) | RAB9ANPC1MAPTGAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0882718-B1 | BENZIMIDAZOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO (JP) | 2005-08-31 | — | — | EP | disclosed |
| US-6352985-B1 | CARDIOVASCULAR DISORDERS OR GASTROINTESTINAL DISORDERS, DIABETES (TYPE II DIABETES), DIABETIC COMPLICATIONS METHOD FOR LOWERING THE BLOOD SUGAR LEVEL OF A PATIENT, | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-03-05 | — | — | US | disclosed |
| EP-0882718-A1 | BENZIMIDAZOLE DERIVATIVES | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-12-09 | — | — | EP | disclosed |